| Literature DB >> 33157227 |
Lise Boon1, Estefania Ugarte-Berzal1, Erik Martens1, Pierre Fiten1, Jennifer Vandooren1, Rik Janssens2, Marfa Blanter2, Karen Yu2, Mieke Boon3, Sofie Struyf2, Paul Proost2, Ghislain Opdenakker4.
Abstract
Matrix metalloproteinases (MMPs) are enzymes with critical roles in biology and pathology. Glycosylation, nitrosylation and proteolysis are known posttranslational modifications (PTMs) regulating intrinsically the activities of MMPs. We discovered MMP citrullination by peptidyl arginine deiminases (PADs) as a new PTM. Upon hypercitrullination, MMP-9 acquired a higher affinity for gelatin than control MMP-9. Furthermore, hypercitrullinated proMMP-9 was more efficiently activated by MMP-3 compared to control MMP-9. JNJ0966, a specific therapeutic inhibitor of MMP-9 activation, inhibited the activation of hypercitrullinated proMMP-9 by MMP-3 significantly less in comparison with control proMMP-9. The presence of citrullinated/homocitrullinated MMP-9 was detected in vivo in neutrophil-rich sputum samples of cystic fibrosis patients. In addition to citrullination of MMP-9, we report efficient citrullination of MMP-1 and lower citrullination levels of MMP-3 and MMP-13 by PAD2 in vitro. In conclusion, citrullination of MMPs is a new PTM worthy of additional biochemical and biological studies.Entities:
Keywords: Activation; Citrullination; Homocitrullination; Matrix metalloproteinase; Posttranslational modification
Year: 2020 PMID: 33157227 DOI: 10.1016/j.matbio.2020.10.005
Source DB: PubMed Journal: Matrix Biol ISSN: 0945-053X Impact factor: 11.583